Though further evidence, e.g., treatment with longer terms or higher doses of anti-PD-L1 antibody in mice exposed to tobacco smoke, is needed, our results demonstrate that antagonizing PD-L1 may be helpful for prevention of lung cancer in smokers. Here, CD274 is linked to lung carcinoma.